11 reports

  • Acute Coronary Syndrome Overview
  • Acute Coronary Syndrome - Discontinued Products

Acute Coronary Syndrome - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Acute Coronary Syndrome – Pipeline Review, H2 2016, provides an overview of the Acute Coronary Syndrome (Cardiovascular) pipeline landscape. Acute coronary syndrome is a...

  • Acute Coronary Syndrome
  • Chronic Disease
  • United States
  • Product Initiative
  • Bayer AG
  • ACUTE CORONARY SYNDROME THERAPEUTICS, GLOBAL, CLINICAL TRIALS BY REGION (%), 2017*
  • ACUTE CORONARY SYNDROME THERAPEUTICS, G7 COUNTRIES, CLINICAL TRIALS BY TRIAL STATUS, 2017*

Acute Coronary Syndrome Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Acute Coronary Syndrome Global Clinical Trials Review, H1, 2017” provides an overview of Acute Coronary Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on...

  • Acute Coronary Syndrome
  • Cardiovascular Disease
  • Clinical Trial
  • World
  • AstraZeneca PLC

Global Acute Coronary Syndrome Epidemiology and Patient Flow Analysis - 2017 ##.

  • Acute Coronary Syndrome
  • Chronic Disease
  • United States
  • World
  • Forecast
  • Latest Clinical Trials News on Acute Coronary Syndrome
  • Acute Coronary Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*

Acute Coronary Syndrome Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Acute Coronary Syndrome Global Clinical Trials Review, H2, 2016" provides an overview of Acute Coronary Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Acute...

  • Acute Coronary Syndrome
  • Cardiovascular Disease
  • Clinical Trial
  • Pharmaceutical
  • World
  • Acute Coronary Syndrome (ACS).
  • Acute Coronary Syndrome Overview

Acute Coronary Syndrome - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Acute Coronary Syndrome - Pipeline Review, H1 2016’, provides an overview of the Acute Coronary Syndrome pipeline landscape. The report provides comprehensive information on the therapeutics under development for Acute Coronary...

  • Acute Coronary Syndrome
  • Cardiovascular Disease
  • Research And Development
  • Therapy
  • Bayer AG
  • Treatment: Acute Coronary Syndrome
  • Pipeline: Acute Coronary Syndrome

The $1.9bn acute coronary syndrome (ACS) market will experience moderate growth over the forecast period, driven by uptake of Brilinta and Xarelto in the secondary-prevention setting. This report addresses the following questions: - How will the updated 2016 treatment guidelines impact the use of new antiplatelet agents...

  • Acute Coronary Syndrome
  • United States
  • AstraZeneca PLC
  • NSTEMI group
  • The Medicines Company

Europe Acute Coronary Syndrome Epidemiology and Patient Flow Analysis - 2017 ##.

  • Acute Coronary Syndrome
  • Europe
  • France
  • Germany
  • Forecast

Acute Coronary Syndrome - Epidemiology Forecast to 2027 ##.

  • Acute Coronary Syndrome
  • France
  • Germany
  • Italy
  • Spain

Acute Coronary Syndrome - Pipeline Insight, 2018 ##.

  • Acute Coronary Syndrome
  • Therapy

Acute Coronary Syndrome - Market Insight, Epidemiology and Market Forecast - 2027 ##.

  • Acute Coronary Syndrome
  • Chronic Disease
  • Pathology
  • United States
  • Market Shares
  • Global Acute Coronary Syndrome (ACS) Market
  • Global Acute Coronary Syndrome (ACS) Market

About ACS ACS is a condition that results in sudden and reduced blood flow to the heart. ACS is a serious cardiovascular disease associated with high healthcare costs, frequent recurrences and hospitalizations, and short-term mortality. On the basis of evidence of heart muscle damage and changes in the ST-tracing of the ECG, ACS is classified...

  • Acute Coronary Syndrome
  • AstraZeneca PLC
  • Bristol-Myers Squibb Company
  • Eli Lilly & Co.
  • GlaxoSmithKline plc